•REALITY OF INFLAMMATORY BOWEL DISEASE IN BRAZILIAN PREGNANT WOMEN (2007/2024)
•Pathobiont-directed mucosal immunotherapy targets Ruminococcus gnavus and remodels host-microbiota interactions in colitis
•Mechanisms and therapeutic perspectives of mucosal glycosylation-innate immunity crosstalk in inflammatory bowel disease (Review)
•Unmet social needs in pediatric patients with inflammatory bowel disease linked to increased risk of missed appointments
•Gut bacterial lauroyl tryptamine reduces GPR183-associated inflammatory responses in human macrophages and T cells in vitro
